Bridgeway Capital Management’s Medtronic MDT Stock Holding History

Bridgeway Capital Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-154,225	Closed	-$18.1M	–	1388
2020 Q4	$18.1M	Sell	154,225 -71,000	-32%	-$7.82M	0.38%	63
2020 Q3	$23.4M	Sell	225,225 -95,600	-30%	-$9.6M	0.54%	37
2020 Q2	$29.4M	Sell	320,825 -9,575	-3%	-$918K	0.59%	42
2020 Q1	$29.8M	Buy	330,400 +59,250	+22%	+$6.3M	0.68%	35
2019 Q4	$30.8M	Buy	+271,150	New	+$29.8M	0.41%	88
2014 Q2	–	Sell	-51,000	Closed	-$3.14M	–	1451
2014 Q1	$3.14M	Hold	51,000	–	–	0.09%	306
2013 Q4	$2.93M	Sell	51,000 -20,100	-28%	-$1.14M	0.09%	317
2013 Q3	$3.79M	Hold	71,100	–	–	0.13%	152
2013 Q2	$3.66M	Buy	+71,100	New	+$3.51M	0.15%	127

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bridgeway Capital Management's MDT Position: Q1 2021 in Review

Bridgeway Capital Management sold out of Medtronic (MDT) in Q1 2021, closing a stake of 154,225 shares — an estimated $18.1M sold.

Bridgeway Capital Management first reported a position in MDT in Q2 2013 and held it in 9 quarters. The position peaked at $30.8M in Q4 2019. 1,976 funds tracked by Wall St. Rank hold MDT as of Q1 2021.

Bridgeway Capital Management reported no remaining Medtronic position as of Q1 2021 after selling out during the quarter.
Bridgeway Capital Management sold 154,225 Medtronic shares in Q1 2021, an estimated $18.1M.
Bridgeway Capital Management first reported a position in Medtronic in Q2 2013 and held it in 9 quarters.
Bridgeway Capital Management's Medtronic position peaked at $30.8M in Q4 2019.
1,976 funds tracked by Wall St. Rank held Medtronic as of Q1 2021.

Based on Bridgeway Capital Management's 13F filing for Q1 2021, filed 17 May 2021.